Copyright Reports & Markets. All rights reserved.

Asia-Pacific Veterinary/Animal Vaccines Market Report 2018

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Veterinary/Animal Vaccines Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Livestock Diseases Market Performance (Volume)
      • 2.1.2 Porcine Diseases Market Performance (Volume)
      • 2.1.3 Poultry Diseases Market Performance (Volume)
      • 2.1.4 Companion Animal Diseases Market Performance (Volume)
      • 2.1.5 Equine Diseases Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Livestock Diseases Market Performance (Value)
      • 2.1.2 Porcine Diseases Market Performance (Value)
      • 2.1.3 Poultry Diseases Market Performance (Value)
      • 2.1.4 Companion Animal Diseases Market Performance (Value)
      • 2.1.5 Equine Diseases Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Inactivated Vaccines Market Performance (Volume)
      • 3.1.2 Live Attenuated Vaccines Market Performance (Volume)
      • 3.1.3 Toxoid Vaccines Market Performance (Volume)
      • 3.1.4 Conjugate Vaccines Market Performance (Volume)
      • 3.1.5 DNA Vaccines Market Performance (Volume)
      • 3.1.6 Recombinant Vaccines Market Performance (Volume)
      • 3.1.7 Subunit Vaccines Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Zoetis Inc. (Pfizer)
      • 4.1.1 Zoetis Inc. (Pfizer) Profiles
      • 4.1.2 Zoetis Inc. (Pfizer) Product Information
      • 4.1.3 Zoetis Inc. (Pfizer) Veterinary/Animal Vaccines Business Performance
      • 4.1.4 Zoetis Inc. (Pfizer) Veterinary/Animal Vaccines Business Development and Market Status
    • 4.2 Merck Animal Health
      • 4.2.1 Merck Animal Health Profiles
      • 4.2.2 Merck Animal Health Product Information
      • 4.2.3 Merck Animal Health Veterinary/Animal Vaccines Business Performance
      • 4.2.4 Merck Animal Health Veterinary/Animal Vaccines Business Development and Market Status
    • 4.3 Merial Inc.
      • 4.3.1 Merial Inc. Profiles
      • 4.3.2 Merial Inc. Product Information
      • 4.3.3 Merial Inc. Veterinary/Animal Vaccines Business Performance
      • 4.3.4 Merial Inc. Veterinary/Animal Vaccines Business Development and Market Status
    • 4.4 Boehringer Ingelheim
      • 4.4.1 Boehringer Ingelheim Profiles
      • 4.4.2 Boehringer Ingelheim Product Information
      • 4.4.3 Boehringer Ingelheim Veterinary/Animal Vaccines Business Performance
      • 4.4.4 Boehringer Ingelheim Veterinary/Animal Vaccines Business Development and Market Status
    • 4.5 Bayer Animal Health
      • 4.5.1 Bayer Animal Health Profiles
      • 4.5.2 Bayer Animal Health Product Information
      • 4.5.3 Bayer Animal Health Veterinary/Animal Vaccines Business Performance
      • 4.5.4 Bayer Animal Health Veterinary/Animal Vaccines Business Development and Market Status
    • 4.6 Elanco Animal Health
      • 4.6.1 Elanco Animal Health Profiles
      • 4.6.2 Elanco Animal Health Product Information
      • 4.6.3 Elanco Animal Health Veterinary/Animal Vaccines Business Performance
      • 4.6.4 Elanco Animal Health Veterinary/Animal Vaccines Business Development and Market Status
    • 4.7 Ceva Animal Health
      • 4.7.1 Ceva Animal Health Profiles
      • 4.7.2 Ceva Animal Health Product Information
      • 4.7.3 Ceva Animal Health Veterinary/Animal Vaccines Business Performance
      • 4.7.4 Ceva Animal Health Veterinary/Animal Vaccines Business Development and Market Status
    • 4.8 Heska Corporation
      • 4.8.1 Heska Corporation Profiles
      • 4.8.2 Heska Corporation Product Information
      • 4.8.3 Heska Corporation Veterinary/Animal Vaccines Business Performance
      • 4.8.4 Heska Corporation Veterinary/Animal Vaccines Business Development and Market Status
    • 4.9 Virbac Inc.
      • 4.9.1 Virbac Inc. Profiles
      • 4.9.2 Virbac Inc. Product Information
      • 4.9.3 Virbac Inc. Veterinary/Animal Vaccines Business Performance
      • 4.9.4 Virbac Inc. Veterinary/Animal Vaccines Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Asia-Pacific Veterinary/Animal Vaccines Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Asia-Pacific Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Asia-Pacific Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 China Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 China Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 China Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Japan Market Performance for Manufacturers
      • 6.2.1 Japan Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Japan Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Japan Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Japan Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Korea Market Performance for Manufacturers
      • 6.3.1 South Korea Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Korea Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Korea Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Korea Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Taiwan Market Performance for Manufacturers
      • 6.4.1 Taiwan Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Taiwan Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Taiwan Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Taiwan Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 India Market Performance for Manufacturers
      • 6.5.1 India Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 India Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 India Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 India Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Southeast Asia Market Performance for Manufacturers
      • 6.6.1 Southeast Asia Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Southeast Asia Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Southeast Asia Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Southeast Asia Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Australia Market Performance for Manufacturers
      • 6.7.1 Australia Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Australia Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Australia Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Australia Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Veterinary/Animal Vaccines Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Veterinary/Animal Vaccines Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Veterinary/Animal Vaccines Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Veterinary/Animal Vaccines Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Asia-Pacific Veterinary/Animal Vaccines Market Performance (Sales Point)

    • 7.1 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Asia-Pacific Veterinary/Animal Vaccines Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Asia-Pacific Veterinary/Animal Vaccines Price (USD/Unit) by Regions 2013-2018
    • 7.4 Asia-Pacific Veterinary/Animal Vaccines Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Asia-Pacific Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 China Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Japan Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Korea Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Taiwan Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 India Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Southeast Asia Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Australia Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Australia Veterinary/Animal Vaccines Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Inactivated Vaccines Industry
    • 11.2 Live Attenuated Vaccines Industry
    • 11.3 Toxoid Vaccines Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Asia-Pacific Veterinary/Animal Vaccines Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 China Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Japan Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Korea Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Taiwan Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 India Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Southeast Asia Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Australia Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Veterinary/Animal Vaccines Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Livestock Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Porcine Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Poultry Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Companion Animal Diseases Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Inactivated Vaccines Sales and and Growth Rate 2019-2024
      • 12.4.3 Live Attenuated Vaccines Sales and and Growth Rate 2019-2024
      • 12.4.4 Toxoid Vaccines Sales and and Growth Rate 2019-2024
      • 12.4.5 Conjugate Vaccines Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Asia-Pacific Veterinary/Animal Vaccines Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Asia-Pacific Veterinary/Animal Vaccines Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Veterinary/Animal Vaccines for these regions, from 2012 to 2023 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

    Asia-Pacific Veterinary/Animal Vaccines market competition by top manufacturers/players, with Veterinary/Animal Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Zoetis Inc. (Pfizer)
    Merck Animal Health
    Merial Inc.
    Boehringer Ingelheim
    Bayer Animal Health
    Elanco Animal Health
    Ceva Animal Health
    Heska Corporation
    Virbac Inc.

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Livestock Diseases
    Porcine Diseases
    Poultry Diseases
    Companion Animal Diseases
    Equine Diseases
    Aquaculture Diseases
    Other

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Veterinary/Animal Vaccines for each application, including
    Inactivated Vaccines
    Live Attenuated Vaccines
    Toxoid Vaccines
    Conjugate Vaccines
    DNA Vaccines
    Recombinant Vaccines
    Subunit Vaccines

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now